As Executive Vice President, MedImmune, I am responsible for biologics research, development and clinical activities. As part of AstraZeneca’s Senior Executive Team, I am tasked with advancing the biologic organisation’s pipeline of drugs targeting cancer, infections, respiratory and inflammatory diseases, cardiovascular and gastrointestinal disorders and pain.